Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 may cause temporary hair loss due to the body's immune response.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Possible link between COVID-19 and hair loss; more research needed.

Some early COVID-19 mutations in patients predicted future common virus mutations.

A woman's hair loss improved with treatment after a COVID-19 infection.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

Interest in COVID-19 hair loss increased during COVID-19 surges, especially in higher-income countries.

Mothers with lower stress during pregnancy but higher stress after birth had infants with lower development scores.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

The article suggests using safety measures and telemedicine for aesthetic dermatology during COVID-19, while some procedures can still be done safely.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

Many hospitalized children with COVID-19 had skin, mouth, or nail changes, with skin rashes being common.

Skin symptoms could help in early COVID-19 diagnosis but more research is needed to confirm their reliability.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Public interest in skin issues changed during COVID-19, with more focus on dry skin, hair problems, and hand eczema.

Educators who survived COVID-19 faced physical, psychological, and social challenges but overcame them with resilience and support, highlighting the need for schools to provide better health and psychological care.

The document's conclusion cannot be provided because the document itself is not accessible or cannot be parsed.

Many healthcare workers who had Covid-19 suffer from long-term symptoms like hair loss and fatigue, especially women.

About 61% of women who had COVID-19 experienced hair loss afterward.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

AGA might indicate higher risk for severe COVID-19.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Many COVID-19 patients have long-term symptoms, especially women, but certain medications may help reduce these symptoms.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.